Literature DB >> 18594803

Embryonal rhabdomyosarcoma as a second malignancy following multimodal therapy for advanced-stage neuroblastoma.

Gurdeep S Mann1, Angela T Byrne, Helen R Nadel, Heather Bray.   

Abstract

Second malignancy as a long-term complication in survivors of advanced-stage neuroblastoma is rare, but it is becoming recognized more frequently. We report an unusual case of a soft-tissue sarcoma developing within a retroperitoneal primary following previous extensive treatment for metastatic neuroblastoma using multimodality imaging including PET/CT.

Entities:  

Mesh：

Year:  2008        PMID： 18594803     DOI： 10.1007/s00247-008-0905-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  8 in total

1.  Long-term complications in survivors of advanced stage neuroblastoma.

Authors:  Caroline Laverdière; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Michael P LaQuaglia; Suzanne Wolden; Kirsten K Ness; James G Gurney; Charles A Sklar
Journal:  Pediatr Blood Cancer       Date:  2005-09       Impact factor: 3.167

2.  Secondary neoplasms after radiotherapy for a childhood solid tumor.

Authors:  Arnold C Paulino; B Zach Fowler
Journal:  Pediatr Hematol Oncol       Date:  2005-03       Impact factor: 1.969

3.  Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.

Authors:  Alberto Garaventa; Claudio Gambini; Giampiero Villavecchia; Andrea Di Cataldo; Luigi Bertolazzi; Maria Rosa Pizzitola; Bruno De Bernardi; Riccardo Haupt
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

4.  Lessons we have learned from our children: cancer risks from diagnostic radiology.

Authors:  Eric J Hall
Journal:  Pediatr Radiol       Date:  2002-07-19

5.  Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group.

Authors:  Gianni Bisogno; Guido Sotti; Yohann Nowicki; Andrea Ferrari; Alberto Garaventa; Ilaria Zanetti; Claudio Favre; Amalia Schiavetti; Paolo Tamaro; Modesto Carli
Journal:  Cancer       Date:  2004-04-15       Impact factor: 6.860

6.  Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.

Authors:  Carole Rubino; Elisabeth Adjadj; Sylvie Guérin; Catherine Guibout; Akhtar Shamsaldin; Marie-Gabrielle Dondon; Dominique Valteau-Couanet; Olivier Hartmann; Mike Hawkins; Florent de Vathaire
Journal:  Int J Cancer       Date:  2003-12-10       Impact factor: 7.396

Review 7.  Fast STIR whole-body MR imaging in children.

Authors:  Christian J Kellenberger; Monica Epelman; Stephen F Miller; Paul S Babyn
Journal:  Radiographics       Date:  2004 Sep-Oct       Impact factor: 5.333

8.  Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN.

Authors:  Arjen Koppen; Rachida Ait-Aissa; Jan Koster; Ingrid Øra; Johannes Bras; Peter G van Sluis; Huib Caron; Rogier Versteeg; Linda J Valentijn
Journal:  Int J Cancer       Date:  2008-04-01       Impact factor: 7.396
  8 in total
  1 in total

1.  Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.

Authors:  Sara M Federico; Heather B Allewelt; Sheri L Spunt; Melissa M Hudson; Jianrong Wu; Catherine A Billups; Jesse Jenkins; Victor M Santana; Wayne L Furman; Lisa M McGregor
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.